Loading…
Employees: 829
Size Bajaj Consumer Care (BAJAJCON.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $551M, the 804th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹396.70 on 6 Nov 2026.
Performance Over six months the shares fell 23.9%, against -17.0% for the median peer and 0.0% for the India market (cap-weighted) — 6th lowest of 21 in its peer set.
Growth Revenue grew 28.6% over the last twelve months (peer median +5.9%); the operating margin is 21.5% (peer median 8.2%).
Valuation It trades at 19.6× forward earnings against a peer median of 19.4× (9th most expensive of 18).
Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +5%, so the hurdle is +10 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 41.4 points above its cost of capital (13.5% WACC).
Next results Next results expected around 3 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹13.1B | ₹11.5B | ₹9.52B | ₹9.69B | ₹9.50B |
| Revenue growth | — | +21% | -2% | +2% | — |
| Gross profit | ₹6.44B | ₹5.28B | ₹3.70B | ₹4.05B | ₹4.01B |
| EBITDA | ₹2.98B | ₹2.15B | ₹1.18B | ₹1.45B | ₹1.35B |
| Net income | ₹2.51B | ₹1.90B | ₹1.25B | ₹1.55B | ₹1.39B |
| Free cash flow | n/a | ₹1.87B | ₹911M | ₹1.53B | ₹1.33B |
| Capital expenditure | n/a | ₹335M | ₹58.0M | ₹48.2M | ₹64.1M |
| Total debt | ₹135M | ₹158M | ₹41.7M | ₹87.5M | ₹92.8M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | BAJAJCON.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -17.9% | -9.4% | 5th lowest of 21 |
| 6-month return | -23.9% | -17.0% | 6th lowest of 21 |
| Distance from 52-week high | -42.7% | -34.9% | 6th lowest of 21 |
| Revenue growth (TTM) | +28.6% | +5.9% | 4th highest of 21 |
| Operating margin | 21.5% | 8.2% | highest of 21 |
| Forward P/E | 19.6× | 19.4× | 9th most expensive of 18 |
| Growth the price implies (Req g, 7 yrs) | 14.6% | 0.4% | 4th most demanding of 15 |
| Growth delivered (Del g) | +5.0% | +7.1% | 5th lowest of 15 |
| Hurdle (Req g minus delivered) | +9.7 pp | -6.8 pp | 3rd most demanding of 15 |
| ROIC minus cost of capital | +41.4 pp | +3.3 pp | highest of 21 |
| EV / EBITDA | 15.7× | 10.8× | 4th most expensive of 11 |
| Net debt / EBITDA | -1.7× | -0.7× | 5th least indebted of 12 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Bajaj Consumer Care BAJAJCON.NS | India | $551M | -24% | +29% | 22% | 19.6× | 14.6% | +5.0% |
| PZ Cussons PZC.L | United Kingdom | $566M | +30% | +5% | 11% | 13.3× | -1.7% | -2.1% |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $464M | -25% | -7% | 4% | n/a | n/a | n/a |
| Milbon 4919.T | Japan | $669M | +30% | +6% | 13% | 22.9× | -3.1% | +8.2% |
| Tianjin Yiyi Hygiene Products 001206.SZ | China | $448M | -15% | -8% | 9% | 20.8× | 2.5% | +6.3% |
| Lafang China 603630.SS | China | $445M | -20% | -3% | 2% | 40.4× | n/a | n/a |
| Jinglv Environment Science & Technology 001230.SZ | China | $415M | -22% | +28% | 11% | 14.7× | n/a | n/a |
| Hangzhou Haoyue Personal Care 605009.SS | China | $750M | -19% | +10% | 6% | 17.7× | 4.7% | +7.7% |
| Liuzhou Liangmianzhen 600249.SS | China | $398M | -19% | -11% | -7% | n/a | n/a | n/a |
| Jyothy Labs JYOTHYLAB.NS | India | $773M | -23% | +5% | 8% | 30.9× | 35.0% | +8.9% |
| McBride MCB.L | United Kingdom | $386M | +11% | +1% | 6% | 8.3× | -0.9% | +6.5% |
| Cosmecca Korea 241710.KS | South Korea | $798M | +25% | +44% | 13% | 14.4× | -5.9% | +13.6% |
| Galaxy Surfactants GALAXYSURF.NS | India | $819M | +13% | +30% | 9% | 18.6× | 18.0% | +13.7% |
| Shandong Hiking International 600735.SS | China | $338M | -29% | -11% | -2% | n/a | -5.7% | +1.5% |
| Hangzhou Coco Healthcare Products 301009.SZ | China | $332M | -26% | +7% | 0% | 119.0× | n/a | n/a |
| Runben Biotechnology 603193.SS | China | $940M | -33% | +13% | 21% | 18.9× | 1.7% | +28.4% |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $944M | +15% | +10% | 11% | 28.9× | 4.3% | +10.8% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $961M | +47% | +54% | 7% | 54.0× | n/a | n/a |
| Noevir 4928.T | Japan | $977M | +3% | +1% | 16% | 19.4× | -4.8% | +4.5% |
| SYoung 300740.SZ | China | $1.00B | -37% | +14% | 3% | 39.6× | 18.1% | +6.1% |
| Yuen Foong Yu Consumer Products 6790.TW | Taiwan | $301M | -7% | -4% | 13% | 13.6× | -14.9% | +1.0% |